Radiation Therapy Guidelines for Parotid Carcinoma

Introduction to Guidelines

The American Society of Clinical Oncology (ASCO) recommends adjuvant radiation therapy for patients with high-grade parotid carcinoma, regardless of stage, due to its infiltrative growth pattern and perineural spread propensity 1, 2
The National Comprehensive Cancer Network (NCCN) guidelines suggest that postoperative radiation therapy should be offered for tumors with high-grade histology, positive margins, perineural invasion, lymph node metastases, lymphovascular invasion, or T3-4 tumors 1, 2

The British guidelines from 2001 took a more conservative stance on adjuvant radiotherapy, reserving it for cases with adverse surgical outcomes or advanced disease 3, 4, 5
In contrast, the 2021 ASCO guidelines establish clear indications for adjuvant radiation therapy based on histology and pathologic features, rather than stage alone 1, 2

The ASCO guidelines recommend postoperative radiation therapy for patients with adenoid cystic carcinoma, regardless of stage, due to its high risk of perineural invasion and local recurrence 1, 2
The guidelines also recommend postoperative radiation therapy for patients with high-grade tumors, positive margins, perineural invasion, lymph node metastases, lymphovascular invasion, or T3-4 tumors 1, 2

The target volume for radiation therapy should include the salivary gland surgical bed and appropriate nodal levels, with a minimum dose of 60 Gy in conventional fractionation 1, 2
For perineural invasion, the involved nerve(s) should receive elective or intermediate dose (46-54 Gy) to the skull base to reduce retrograde nerve failure risk 1, 2

Adjuvant radiation therapy should not be withheld from completely resected high-grade tumors based on negative margins alone, as the modern evidence supports adjuvant treatment for high-grade histology regardless of margin status 1, 2
Facial nerve preservation should not compromise oncologic resection, but when nerve function is intact preoperatively and a dissection plane exists, nerve preservation with adjuvant radiation therapy provides superior functional outcomes compared to nerve sacrifice 6